Black Rock Inc. Liquidia Corp Transaction History

Black Rock Inc.

$4.23 Trillion
Q1 2024

A detailed history of Black Rock Inc. transactions in Liquidia Corp stock. As of the latest transaction made, Black Rock Inc. holds 3,747,491 shares of LQDA stock, worth $44.3 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

3,747,491

Previous 3,529,461 6.18%

Holding current value

$44.3 Million

Previous $42.5 Million 30.18%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$11.35 - $16.73 $2.47 Million - $3.65 Million	218,030 Added 6.18%	3,747,491 $55.3 Million
Q4 2023 Feb 13, 2024	BUY	$5.77 - $12.19 $1.29 Million - $2.72 Million	222,882 Added 6.74%	3,529,461 $42.5 Million
Q3 2023 Nov 13, 2023	BUY	$6.27 - $8.15 $85,347 - $110,937	13,612 Added 0.41%	3,306,579 $21 Million
Q2 2023 Aug 11, 2023	BUY	$6.63 - $9.9 $359,743 - $537,174	54,260 Added 1.68%	3,292,967 $25.8 Million
Q1 2023 May 12, 2023	SELL	$5.72 - $7.91 $251,994 - $348,475	-44,055 Reduced 1.34%	3,238,707 $22.4 Million

Q4 2022 Feb 13, 2023	BUY	$4.68 - $6.54 $870,821 - $1.22 Million	186,073 Added 6.01%	3,282,762 $20.9 Million
Q3 2022 Nov 14, 2022	BUY	$3.73 - $8.39 $139,942 - $314,776	37,518 Added 1.23%	3,096,689 $16.8 Million
Q2 2022 Aug 12, 2022	BUY	$3.37 - $7.55 $7.46 Million - $16.7 Million	2,212,786 Added 261.44%	3,059,171 $13.3 Million
Q1 2022 May 12, 2022	BUY	$5.14 - $7.38 $15,635 - $22,449	3,042 Added 0.36%	846,385 $6.08 Million
Q4 2021 Feb 10, 2022	BUY	$2.71 - $5.17 $12,636 - $24,107	4,663 Added 0.56%	843,343 $4.11 Million
Q3 2021 Nov 09, 2021	SELL	$2.28 - $2.95 $19,195 - $24,836	-8,419 Reduced 0.99%	838,680 $2.32 Million
Q2 2021 Aug 11, 2021	BUY	$2.51 - $3.11 $2.13 Million - $2.63 Million	847,099 New	847,099 $2.42 Million

Others Institutions Holding LQDA

# of Institutions

157

Shares Held

35.5M

Call Options Held

1.68M

Put Options Held

1.17M

View Full List

About Liquidia Corp

Ticker LQDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 64,362,300
Market Cap $761M
Description
Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension. It also distributes generic treprostinil inje...

More about LQDA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.

Account